HDAC9 and central nervous system cancer: The expression levels of HDAC1 (Figure 10A), HDAC3 (Figure 10B), HDAC7 (Figure 10E), and HDAC9 (Figure 10F) were significantly elevated in the glioma patients compared with the nontumor group.